Sesen Bio
Biotechnology ResearchMassachusetts, United States11-50 Employees
We are passionate in our commitment to save and improve the lives of patients. Sesen Bio is a late-stage company developing fusion protein medicines for the treatment of patients with cancer. In February 2021, the FDA accepted for filing the Company’s BLA for Vicineum™, a potential best-in-class treatment for non-muscle invasive bladder cancer.